MedTrace Logo

Antimicrobial Resistance in Hospitals From Meta, Colombia

NCT06044272 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 10000

Last updated 2024-12-12

No results posted yet for this study

Summary

Introduction: Healthcare-associated infections cause a burden in morbidity and mortality, and they increase the financial cost of care. Nevertheless, they are not limited to setting factors, and several community conditions and contexts are linked. Clinical laboratories from hospitals report monthly to the Public Health Laboratory.

Objective: The study aims to establish the antimicrobial resistance profile of the most significant bacteria involved in healthcare-associated infections in Meta State hospitals.

Methodology: The researchers designed a retrospective observational trial with the records from samples and origin, microbial findings, and antibiogram. The outcome was the mechanism for antimicrobial resistance. The information from the State Public Health Laboratory database was exported to Excel for analysis.

Conclusions: The outlook of Enterobacteriaceae and Staphylococcus aureus antimicrobial resistance in hospitals from Meta State will be revealed. Comprehensive strategies for mitigation, including continuous microbiological surveillance, are needed.

Conditions

  • Increased Drug Resistance

Interventions

OTHER

Factors associated

Factors associated with the type of resistance by microorganisms.

Sponsors & Collaborators

  • Cooperative University of Colombia

    collaborator OTHER

  • Hospital Departamental de Villavicencio

    lead OTHER

Principal Investigators

  • Norton Perez, MD · Cooperative University of Colombia

Eligibility

Max Age
130 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-09-01
Primary Completion
2023-11-30
Completion
2024-06-30

Countries

  • Colombia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06044272 on ClinicalTrials.gov